Vedanta Biosciences “significantly” reduced its headcount to maintain progress and focus resources on a Phase III study of oral drug candidate VE303 for recurrent Clostridioides difficile infection (rCDI).
All entries for: Vedanta Biosciences
August 15, 2025
Vedanta Biosciences
Layoffs
Cambridge, MA
51-200 employees
Bausch Health has laid off 49 employees in Petaluma, California, and is closing that location. The cuts, effective Aug. 13, represent a small part of the Canada-based company’s workforce. Bausch employed about 20,700 employees—including 8,100 in the U.S. and Canada—as of Dec. 31
Disease Area: Gastrointestinal, Immune Diseases, Multiple
Drug Type: Biologic